Powder: -20°C for 3 years | In solvent: -80°C for 1 year
WEHI-539 is a selective Bcl-XL inhibitor (IC50: 1.1 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 623.00 | |
50 mg | 10-14 weeks | $ 810.00 | |
100 mg | 10-14 weeks | $ 1,249.00 |
Description | WEHI-539 is a selective Bcl-XL inhibitor (IC50: 1.1 nM). |
Targets&IC50 | Bcl-xL:1.1 nM |
In vitro | WEHI-539 induces noticeable PARP cleavage in Ovcar-4 (5 μM in Ovcar-4.) and Ovsaho (1 μM in Ovsaho) cells. WEHI-539 augments Carboplatin induced caspase 3/7 activity, PARP cleavage, and annexin V labeling.[2] |
Molecular Weight | 583.72 |
Formula | C31H29N5O3S2 |
CAS No. | 1431866-33-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
WEHI-539 1431866-33-9 Apoptosis BCL WEHI539 WEHI 539 inhibitor inhibit